We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role ...

Angelini Pharma has announced that it will acquire Catalyst Pharmaceuticals in a deal worth around $4.1bn (3.5bn euros).

Novartis’ radiogland therapy (RLT) Pluvicto – lutetium Lu 177 vipivotide tetraxetan – has received its first approval in Europe as a treatment for advanced prostate cancer from the Medicines and ...

Langland has appointed Victoria Kent as Managing Partner, Medical Strategy & Education, with responsibility for all medical ...

Eli Lilly has announced an additional investment of $4.5bn across two of its three sites in Indiana in the US, bringing the ...

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, ...

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month. Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month. Explore real patient conversations about ...

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to ...

GC Therapeutics has appointed Stefan Irion as Chief Scientific Officer (CSO). Irion brings more than two decades of ...

Sanofi’s Tzield (teplizumab) has received expanded approved from the US FDA, allowing it to be used for children aged one ...

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and ...